Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDLI recall process conference

This article was originally published in The Gray Sheet

Executive Summary

FDLI recall process conference: Deputy Director of FDA's Division of Emergency and Investigational Operations Ellen Morrison is scheduled to speak March 6 about the agency's policy on domestic and international enforcement trends for medical devices, drugs and biologics at the Food and Drug Law Institute meeting, which will be held at The Madison Hotel in Washington, D.C. Lillian Gill, director of the device center's Office of Compliance, will take part in a panel on "The Role of the Field, Streamlining, and Uniformity between Centers." For more information, call FDLI at 202/371-1420...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel